|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-4.08/-10.80
|
企业价值
48.88M
|
资产负债 |
每股账面净值
0.41
|
现金流量 |
现金流量率
--
|
损益表 |
收益
68.00K
|
每股收益
1.95
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/05 02:13 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. |